Mental Health Clinics in Savanna, IL Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Jane Addams Community Mental Health Center Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2107 Chicago Ave, Savanna, IL 61074 Phone: 815-273-3323 |
News Archive
First evidence of neurotrophic factors improving status of degenerating dopamine neurons in Parkinson's brains
Ceregene, Inc., a biopharmaceutical company, reported today that its scientists and collaborators have published new experimental findings in support of its Parkinson's disease program which appeared as the lead article in the current issue of Movement Disorders. The publication reports the first evidence that gene transfer can provide targeted expression of a neurotrophic factor, i.e., neurturin or NRTN, intended to restore and preserve dying neurons.
Eribulin drug has minor added benefit in one patient group, indication of lesser benefit in others
Eribulin (trade name: Halaven) is approved for women with locally advanced or metastatic breast cancer in whom the disease has progressed despite prior drug therapy. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether the drug offers an added benefit over the appropriate comparator therapy in these patient groups.
NCI awards LSUHSC-NOLA Louisiana Tumor Registry $12 million SEER contract
The Louisiana Tumor Registry (LTR) at the LSU Health Sciences Center New Orleans School of Public Health has been awarded a $12 million contract over seven years by the National Cancer Institute to continue its work as a SEER (Surveillance, Epidemiology and End Results) Program-designated cancer registry. There are 18 competitively awarded SEER cancer registries in the United States.
Results from study of Rituxan in rheumatoid arthritis show promise
Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.
› Verified 5 days ago